Yeah, I don’t want to imply that I strongly support the original claims. I think there are lots of very serious problems with incentives and epistemics in science, but nevertheless that both the incentives and the epistemics of scientists are unusually good in important ways.
(As an anecdote that probably shouldn’t be taken as strong evidence, but that I found striking, I once tried out the 2-4-6 test on my lab, and IIRC something like two-thirds of members got the right answer first-time, and both group leaders present did so fairly quickly.)
I’m also very worried about the effects of corporate funding on research, at least in some domains.
Yeah, the more I looked into the guy, the more his critique fit into context. His work finds a home on some websites of questionable repute. haha
And as you point out, the people you meet in academia generally don’t tend to be as he’s characterized them.
I would be willing to bet that he has a financial motive to argue against the prevailing scientific consensus, just as we see in other instances where facts turn out to be inconvenient for corporate interests.
Yeah, I don’t want to imply that I strongly support the original claims. I think there are lots of very serious problems with incentives and epistemics in science, but nevertheless that both the incentives and the epistemics of scientists are unusually good in important ways.
(As an anecdote that probably shouldn’t be taken as strong evidence, but that I found striking, I once tried out the 2-4-6 test on my lab, and IIRC something like two-thirds of members got the right answer first-time, and both group leaders present did so fairly quickly.)
I’m also very worried about the effects of corporate funding on research, at least in some domains.
Yeah, the more I looked into the guy, the more his critique fit into context. His work finds a home on some websites of questionable repute. haha
And as you point out, the people you meet in academia generally don’t tend to be as he’s characterized them.
I would be willing to bet that he has a financial motive to argue against the prevailing scientific consensus, just as we see in other instances where facts turn out to be inconvenient for corporate interests.